0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Review | 
Anita Kohli, MD, MS; Ashton Shaffer, BA; Amy Sherman, MD; et al.
JAMA. 2014;312(6):631-640. doi:10.1001/jama.2014.7085.
Includes: CME, Supplemental Content

Original Investigation | 
Wen-Hung Chung, MD, PhD; Wan-Chun Chang, MS; Yun-Shien Lee, PhD; et al.
JAMA. 2014;312(5):525-534. doi:10.1001/jama.2014.7859.
Includes: Supplemental Content

Clinical Trials Update | 
Anita Slomski
JAMA. 2014;312(4):327. doi:10.1001/jama.2014.9150.

Health Agencies Update | 
Bridget M. Kuehn, MSJ
JAMA. 2014;312(4):328. doi:10.1001/jama.2014.9120.

Health Agencies Update | 
Bridget M. Kuehn, MSJ
JAMA. 2014;312(4):328. doi:10.1001/jama.2014.9118.

Health Agencies Update | 
Bridget M. Kuehn, MSJ
JAMA. 2014;312(4):328. doi:10.1001/jama.2014.8885.

Research Letter | 
Nikolai Madrid Scheller, MB; Björn Pasternak, MD, PhD; Henrik Svanström, MSc; et al.
JAMA. 2014;312(2):187-188. doi:10.1001/jama.2014.2198.

Viewpoint | 
Jonathan Silver, MD, MBA
JAMA. 2014;312(1):23-24. doi:10.1001/jama.2014.6672.

Clinical Trials Update | 
Anita Slomski
JAMA. 2014;311(24):2472. doi:10.1001/jama.2014.7643.

Medical News & Perspectives | 
Bridget M. Kuehn, MSJ
JAMA. 2014;311(24):2470. doi:10.1001/jama.2014.7533.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Internal Medicine
Research Letter  | 
Trends in Boxed Warnings and Withdrawals for Novel Therapeutic Drugs, 1996 Through 2012
Christine M. Cheng, PharmD; Jaekyu Shin, PharmD, MS; B. Joseph Guglielmo, PharmD
JAMA Dermatology
Research Letter  | 
Risk for Nevus Transformation and Melanoma Proliferation and Invasion During Natalizumab Treatment:  Four Years of Dermoscopic Follow-up With Immunohistological Studies and Proliferation and Invasion Assays
Momen Pharaon, MD; Mélanie Tichet, MSc; Christine Lebrun-Frénay, MD, PhD; et al.
JAMA Internal Medicine
Viewpoint  | 
The Food and Drug Administration’s Role in Promoting Consistent Labels for Generic Drugs
Jon D. Duke, MD, MS; Aaron S. Kesselheim, MD, JD
JAMA Ophthalmology
Original Investigation  | 
Combined Intravitreal Melphalan and Topotecan for Refractory or Recurrent Vitreous Seeding From Retinoblastoma
Fariba Ghassemi, MD; Carol L. Shields, MD; Hadi Ghadimi, MD; et al.